Status:
COMPLETED
Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide
Lead Sponsor:
Materno-Perinatal Hospital of the State of Mexico
Collaborating Sponsors:
Laboratorios Liomont
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The new coronavirus outbreak has led to a public health emergency of international concern, putting all health organizations on high alert. As part of the hygienic measures, isolation and reinforcemen...
Detailed Description
Coronaviruses (CoV) are positive-stranded single-stranded RNA viruses that infect a wide range of hosts. The new coronavirus outbreak has led to a public health emergency of international concern, put...
Eligibility Criteria
Inclusion
- COVID-19 positive patients by clinical criteria.
Exclusion
- Patients who have inherent contraindications to nitazoxanide.
- Patients with inflammatory bowel disease.
Key Trial Info
Start Date :
May 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04406246
Start Date
May 21 2020
End Date
December 31 2020
Last Update
March 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Materno-Perinatal Hospital "Mónica Pretelini"
Toluca, Mexico, 50130